References
- Löwenberg B, Downing J R, Burnett A. Acute myeloid leukemia. New Engl J Med 1999; 341: 1051–1062
- Schiffer C A, Dodge R, Larson R A. Long-term follow-up of Cancer and Leukemia Group B studies in acute myeloid leukemia. Cancer 1997; 80: 2210–2214
- Preisler H D, Anderson K, Rai K, Cuttner J, Yates J, DuPre E, et al. The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years. Br J Haematol 1989; 71: 189–194
- Dann E J, Gillis S, Rowe J M. Late relapse following autologous bone marrow transplantation for acute myelogenous leukemia: case report and review of the literature. Leukemia 1995; 9: 1072–1074
- Frassoni F, Labopin M, Gluckman E, Prentice H G, Gahrton G, Mandelli F, et al. Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia 1994; 8: 924–928
- Cortes J E, Kurzrock R, Kantarjian H M. Future clinical implications for farnesyl transferase inhibitors in hematologic malignancies. Semin Hematol 2003; 39: 26–30
- Hiddemann W, Kern W, Schoch C, Fonatsch C, Heinecke A, Wormann B, et al. Management of acute myeloid leukemia in elderly patients. J Clin Oncol 1999; 17: 3569–3576
- Kantarjian H M, Keating M J, Walters R S, McCredie K B, Freireich E J. The characteristics and outcome of patients with late relapse acute myelogenous leukemia. J Clin Oncol 1988; 6: 232–238
- Leopold L H, Willemze R. The treatment of acute myeloid leukemia in first relapse: a comprehensive review of the literature. Leuk Lymphoma 2002; 43: 715–1727
- Craddock C, Tauro S, Moss P, Grimwade D. Biology and management of relapsed acute myeloid leukaemia. Br J Haematol 2005; 129: 18–34
- Appelbaum F R, Kopecky K J. Long-term survival after chemotherapy for acute myeloid leukemia: the experience of the Southwest Oncology Group. Cancer 1997; 80: 2199–2204
- Giles F, O'Brien S, Cortes J, Verstovsek S, Bueso-Ramos C, Shan J, et al. Outcome of patients with acute myelogenous leukemia after second salvage therapy. Cancer 2005; 104: 547–554
- Konrad M, Metzler M, Panzer S, Ostreicher I, Peham M, Repp R, Haas O A, et al. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. Blood 2003; 101: 3635–3640
- Tratkiewicz J A, Szer J. Loss of natural killer activity as an indicator of relapse in acute leukaemia. Clin Exp Immunol 1990; 80: 241–246
- Indraccolo S, Stievano L, Minuzzo S, Tosello V, Esposito G, Piovan E, et al. Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment. Proc Natl Acad Sci USA 2006; 103: 4216–4221
- Pedersen-Bjergaard J, Andersen M K, Christiansen D H, Nerlov C. Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 2002; 99: 1909–1912
- Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, et al. Proposals for the classification of the acute leukaemias. French – American – British (FAB) co-operative group. Br J Haematol 1976; 33: 451–458
- Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French – American – British Cooperative Group. Ann Intern Med 1985; 103: 620–625
- Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 1995; 86: 3542–3552
- Chong G, Byrnes G, Szer J, Grigg A. Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy. Bone Marrow Transplant 2000; 26: 1011–1015
- Koc Y, Miller K B, Schenkein D P, Daoust P, Sprague K, Berkman E. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer 1999; 85: 608–615